MedTrace Logo

Longitudinal Endpoint Assessment of Disease Burden in HD

NCT06475898 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-09-10

No results posted yet for this study

Summary

LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.

Conditions

  • Huntington Disease

Sponsors & Collaborators

  • University of Rochester Center for Health + Technology

    collaborator UNKNOWN

  • Modality.AI, Inc

    collaborator UNKNOWN

  • Neurotargeting LLC

    collaborator INDUSTRY

  • Huntington Study Group

    lead NETWORK

Principal Investigators

  • Jamison Seabury · University of Rochester Center for Health + Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-25
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06475898 on ClinicalTrials.gov